Celcuity (CELC) Other financing activities (2017 - 2023)
Celcuity (CELC) reported Other financing activities of $1.1 million for Q3 2023, down 9.36% on a YoY basis from $1.2 million in Q3 2022, and down 13.18% quarter-over-quarter from $1.3 million in Q2 2023.
Celcuity (CELC) Other financing activities (2017 - 2023) Analysis & Trends
Celcuity has reported Other financing activities for 7 years, with the latest figure at $1.1 million in Q3 2023.
- For the quarter ending Q3 2023, Other financing activities fell 9.36% year-over-year to $1.1 million; the trailing twelve-month figure through Dec 2023 stood at $2.4 million (changed N/A YoY), and the FY2023 full-year result was $2716.0, changed N/A from the prior year.
- Other financing activities for Q3 2023 stood at $1.1 million, down from $1.3 million in the prior quarter.
- The five-year high for Other financing activities was $1.5 million in Q2 2022, with the low at -$680135.0 in Q4 2019.
- Historically, Other financing activities has averaged $547554.9 across 5 years, with a median of $449098.0 in 2021.
- Annual changes were most pronounced in 2019 — Other financing activities slumped 1333.51% — and 2022, when it jumped 181.22%.
- Celcuity's Other financing activities stood at -$680135.0 in 2019, then jumped by 166.01% to $448947.0 in 2020, then rose by 20.35% to $540317.0 in 2021, then surged by 126.36% to $1.2 million in 2022, then decreased by 9.36% to $1.1 million in 2023.
- The last three Other financing activities figures came in at $1.1 million (Q3 2023), $1.3 million (Q2 2023), and $2716.0 (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 1.11 Mn |
| Sep 30, 2023 | 1.11 Mn |
| Jun 30, 2023 | 1.28 Mn |
| Jun 30, 2023 | 1.28 Mn |
| Mar 31, 2023 | 2,716.00 |
| Mar 31, 2023 | 2,716.00 |
| Sep 30, 2022 | 1.22 Mn |
| Sep 30, 2022 | 1.22 Mn |
| Jun 30, 2022 | 1.52 Mn |
| Jun 30, 2022 | 1.52 Mn |
| Mar 31, 2022 | 756,271.00 |
| Mar 31, 2022 | 756,271.00 |
| Jun 30, 2021 | 540,317.00 |
| Jun 30, 2021 | 540,317.00 |
| Mar 31, 2021 | 449,098.00 |
| Mar 31, 2021 | 449,098.00 |
| Sep 30, 2020 | 448,947.00 |
| Sep 30, 2020 | 448,947.00 |
| Jun 30, 2020 | 423,193.00 |
| Jun 30, 2020 | 423,193.00 |